Growth-inhibitory signals by activin a do not affect anticancer drug-sensitivity and acquired multi-drug-resistance in human ovarian endometrioid adenocarcinoma OVK-18 cells

Oncology Reports

Volumn 11, Issue 3, 2004, Pages 667-671

  Tanaka, Tetsuji ^a   Toujima, Saori ^a   Umesaki, Naohiko ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Activin; Apoptosis; Drug resistance; Drug sensitivity; Ovarian cancer

Indexed keywords

ACTIVIN; ACTIVIN A; ANTINEOPLASTIC AGENT; INHIBIN;

ARTICLE; CELL DIVISION; DOSE RESPONSE; DRUG RESISTANCE; FEMALE; FLOW CYTOMETRY; HUMAN; MULTIDRUG RESISTANCE; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY; SENSITIVITY AND SPECIFICITY; TUMOR CELL LINE;

ACTIVINS; ANTINEOPLASTIC AGENTS; CELL DIVISION; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; INHIBIN-BETA SUBUNITS; OVARIAN NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 4644357485     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.11.3.667     Document Type: Article

References (17)

1. Nishihara T, Okahashi N and Ueda N: Activin A induces apoptotic cell death. Biochem Biophys Res Commun 197: 985-991, 1993. (Pubitemid 24034667)
2. Yamato K, Koseki T, Ohguchi M, Kizaki M, Ikeda Y and Nishihara T: Activin A induction of cell-cycle arrest involves modulation of cyclin D2 and p21CIP1/WAF1 in plasmacytic cells. Mol Endocrinol 11: 1044-1052, 1997. (Pubitemid 27278827)
3. Ishisaki A, Yamato K, Hashimoto S, Nakao A, Tamaki K, Nonaka K, Dijke P, Sugino H and Nishihara T: Differential inhibition of Smad6 and Smad7 on bone morphogenetic protein- and activin-mediated growth arrest and apoptosis in B cells. J Biol Chem 274: 13637-13642, 1999.
4. Fukuchi Y, Kizaki M, Yamato K, Kawamura C, Umezawa A, Hata Ji, Nishihara T and Ikeda Y: Mcl-1, an early-induction molecule, modulates activin A-induced apoptosis and differentiation of CML cells. Oncogene 20: 704-713, 2001. (Pubitemid 32179339)
5. Wang QF, Tilly KI, Tilly JL, Preffer F, Schneyer AL, Crowley WF Jr and Sluss PM: Activin inhibits basal and androgen-stimulated proliferation and induces apoptosis in the human prostatic cancer cell line, LNCaP. Endocrinology 137: 5476-5483, 1996. (Pubitemid 26423113)
6. Kin S and Ying SY: Differentially expressed genes in activin-induced apoptotic LNCaP cells. Biochem Biophys Res Commun 257: 187-192, 1999.
7. Chen W, Woodruff TK and Mayo KE: Activin A-induced HepG2 liver cell apoptoosis: involvement of activin receptors and smad proteins. Endocrinology 141: 1263-1272, 2000. (Pubitemid 32260471)
8. Yokomuro S, Tsuji H, Lunz JG III, Sakamoto T, Ezure T, Murase N and Demetris AJ: Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor betal, and activin A: comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cells. Hepatology 32: 26-35, 2000. (Pubitemid 30432362)
9. Choi KC, Kang SK, Tai CJ, Auersperg N and Leung PC: The regulation of apoptosis by activin and transforming growth factor-beta in early neoplastic and tumorigenic ovarian surface epithelium. J Clin Endocrinol Metab 86: 2125-2135, 2001. (Pubitemid 32472930)
10. Tanaka T, Toujima S, Otani T, Minami S, Yamoto M and Umesaki N: Expression and function of activin receptors in human endometrial adenocarcinoma cells. Int J Oncol 23: 657-663, 2003.
11. Miyazono K, Duke PT and Heldin C-H: TGF-β signaling by smad proteins. Adv Immunol 75: 115-157, 2000.
12. Valderrama-Carvajal H, Cocolakis E, Lacerte A, Lee EH, Krystal G, Ali S and Lebrun JJ: Activin/TGF-beta induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP. Nat Cell Biol 4: 963-969, 2002. (Pubitemid 35469426)
13. Otani T, Minami S, Yamoto M and Umesaki N: Production of activin A in hyperplasia and adenocarcinoma of the human endometrium. Gynecol Oncol 83: 31-38, 2001. (Pubitemid 32959876)
14. Di Simone N, Schneyer AL, Caliandro D, Castellani R and Caruso A: Regulation of endometrial adenocarcinoma cell proliferation by activin-A and its modulation by 17beta-estradiol. Mol Cell Endocrinol 192: 187-195, 2002. (Pubitemid 34667236)
15. Uehara S, Abe H, Hoshiai H, Yajima A and Suzuki M: Establishment and characterization of ovarian endometrioid carcinoma cell line. Gynecol Oncol 17: 314-325, 1984. (Pubitemid 14174344)
16. Ishiwata I, Ishiwata C, Soma M, Arai J, Ishikawa H: Establishment of human endometrial adenocarcinoma cell line containing estradiol-17β and progesterone. Gynecol Oncol 17: 281-290, 1984. (Pubitemid 14174339)
17. Lefkovits I: Limiting dilution analysis. In: Immunological Methods. Academic Press, pp355-370, 1979.